发明名称 |
Treatment of multiple sclerosis (MS) with campath-1H |
摘要 |
A method for treatment of multiple sclerosis (MS) with Campath-1H with significant efficacy and a favourable safety profile is which offers an acceptable benefit/risk ratio. Especially described is the use of Campath-1H (alemtuzumab) for the production of a medicament for the treatment of multiple sclerosis (MS), comprising a first treatment cycle followed by at least one further treatment cycle of Campath-1 (alemtuzumab), in which each treatment cycle comprises 1-5 daily doses which are applied on consecutive days, wherein the daily dose is >0 and ‰¤ 12 mg, and wherein each treatment cycle is separated from the next cycle by at least 1 - 24 months. Also are treatment regimens comprising the administration of less than 12 mg/day of Campath-1 for a period of 1-5 consecutive days. |
申请公布号 |
EP2433649(A2) |
申请公布日期 |
2012.03.28 |
申请号 |
EP20110189431 |
申请日期 |
2007.09.11 |
申请人 |
ALCAFLEU MANAGEMENT GMBH & CO. KG;GENZYME CORPORATION |
发明人 |
SACHSE, ANDREAS;MARGOLIN, DAVID HARRIS |
分类号 |
A61K39/395;A61P29/00;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|